Expected Non-Melanoma Skin (Keratinocytic) Cancer incidence in New Zealand for 2018

This report estimates the numbers of diagnoses and the incidence rate of Non-Melanoma Skin (Keratinocytic) Cancer (KC) in New Zealand based on data extracted from a regional collection of pathology records of skin biopsies taken in 2009 to 2013.

One of the key findings was that over 90,400 people will be diagnosed with at least one in situ or invasive KC in 2018.  For Māori it is projected that in 2018 there will be 388 people diagnosed with KC, 651 presentations to a doctor in which a biopsy will be taken for KC and 758 separate KC diagnoses. In non-Māori it is projected that in 2018 there will be 90,077 people diagnosed with KC, 177,855 presentations for KC biopsies, and 229,867 diagnoses of KC.